Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06242249 · UNKNOWN
Trial details
- NCT number
- NCT06242249
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2026-04-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.